On March 31, 2022, the company released the investor relations activity record table, and the company accepted a survey of 7 institutional units on March 31, 2022, and the institutional types are fund companies and securities companies.
Q: What are the advantages of orthopedic surgical robots compared to traditional surgery?
A: 1) The application of orthopedic surgical robots can help doctors better realize the minimally invasive, standardized and intelligent clinical treatment methods. (1) Promote the minimally invasive surgery of conventional surgery for pelvic fracture repair surgery, and the traditional surgical method of doctors is "open steel plate internal fixation surgery". This traditional procedure has the following characteristics: large anterior and posterior joint incisions, large intraoperative bleeding, long surgical time, and the need to load multiple bone plates. Therefore, on the one hand, traditional surgery has great physical damage to patients and is prone to complications; on the other hand, due to the high cost of bone grating plates, hospitalization costs, etc., it brings financial pressure to patients.
With the assistance of orthopedic surgical robots, doctors can use "channel screw internal fixation" to accurately complete the insertion of multiple screws, compared with "open steel plate internal fixation surgery", the operation uses screws instead of bone plates, using a minimally invasive mode, small incision, surgery time and bleeding volume is greatly reduced. As a result, the patient's soft tissue damage is small, the rehabilitation cycle is shortened, and the medical expenses are reduced.
For patients who are difficult to nail in conventional surgery of pelvic and acetabular areas, as well as some patients who are inconvenient to make multiple nail attempts due to osteoporosis, better surgical results can be achieved with the assistance of orthopedic surgical robots.
(2) To achieve the standardization of complex surgery for femoral neck fractures, "screw internal fixation" is generally used, but in the absence of robot-assisted surgery, the surgical effect is not ideal. The operation requires the 3 screws to be kept parallel with each other, and the traditional freehand surgery relies heavily on the doctor's experience, and corrects the screw insertion direction through multiple fluoroscopes during the operation, and the surgical effect may be poor due to the multiple correction of the screws after the operation.
After the orthopedic surgical robot assists the implementation of surgery, the parallelism and dispersion of the hollow screw can achieve the requirements of the simulated image. Doctors use orthopedic surgical robots to operate better than freehand operations, which greatly improves the surgical effect. Other disorders that occur with the femoral head, such as the hip abnormalities that are most common in adolescence (e.g., spondylophysis of the femoral head), can lead to complications such as ischemic necrosis of the femoral head and degenerative arthritis if left untreated. With the help of orthopedic surgical robots, doctors can plan multiple screw paths at a time in the computer system, and accurately drill into the guide needle under the guidance of the robot, with an accuracy of sub-millimeters, which not only shortens the surgical time and is firmly fixed, but also reduces the secondary damage to the patient and intraoperative radiation, greatly improving the efficiency and quality of surgery.
(3) Promote the intelligence of difficult surgery. Humans are vertebrates, the upper spine is close to the brain, close to the central nervous system of life that controls the heartbeat of breathing, and the peripheral nerves and blood vessels are densely packed. Therefore, upper spine surgery is also known as "the jewel in the crown of orthopedic surgery", which requires extremely high positioning accuracy.
The company's orthopedic surgical robot can transform the doctor's surgical planning into a robot with precise positioning, reduce the dependence on the doctor's experience, improve the accuracy of the operation to the sub-millimeter level, and help the doctor complete the difficult operation. With the assistance of orthopedic surgical robots, medical institutions at all levels can also carry out similar difficult surgeries in the future, which will help improve the treatment level of primary medical institutions.
2) Orthopedic surgery robot can help doctors solve the pain points of traditional orthopedic surgery and realize the short-term learning curve of orthopedic surgeons. The learning curve of traditional orthopedic surgeons is long, and it takes many years of experience from obtaining a doctor's qualification certificate to being able to perform complex surgeries, resulting in a shorter "golden practice time" for orthopedic surgeons. Orthopedic surgical robots can transform a doctor's surgical planning into a stable and precise positioning of the robot, reducing the dependence of orthopedic surgery on the doctor's experience. Orthopedic surgeons at all levels of medical institutions can learn to use orthopedic surgical robots after short-term training, improve the surgical level and accuracy of general orthopedic doctors, greatly shorten the learning time of doctors, and then extend the "golden practice time" of orthopedic doctors, which helps to promote the construction of orthopedics.
The application of orthopedic surgical robots has reduced medical risks and enabled primary hospitals to have the ability to perform difficult surgeries. In the future, with the help of the "remote planning" technology that separates planning and operation, through remote collaboration, the clinical use of orthopedic surgical robots will help solve the situation of "difficult to see a doctor, expensive to see a doctor, and untimely treatment" caused by the uneven distribution of medical resources, which will help the overall improvement of the level of orthopedic treatment in mainland China, and ultimately promote hierarchical diagnosis and treatment to achieve balanced and equal medical resources.
Q: What is the market acceptance of the company's orthopedic surgical robot products?
A: After years of market promotion, domestic orthopedic surgeons and patients have a considerable degree of understanding of the surgical safety and reliability of orthopedic surgical robots, as well as the outstanding advantages compared with traditional surgery, and the acceptance of orthopedic surgical robot surgery is rapidly improving.
With the inclusion of orthopedic surgical robot surgery costs into medical insurance reimbursement has made a breakthrough in Beijing, such as the progress of medical insurance in other provinces and cities across the country, which will bring about a significant reduction in the burden of patients and a significant increase in the surgical volume of orthopedic surgical robots, and the economic benefits of hospitals purchasing and using orthopedic surgical robots will be more and more reflected.
The implementation of orthopedic consumables with volume procurement has greatly reduced patients' expenditure on orthopedic implants, and patients will have more affordability to choose orthopedic surgical robot surgery that can bring a better surgical experience.
Q: What are the policies related to the surgical robotics industry?
A: 1) "Made in China 2025" proposed: "Improve the innovation ability and industrialization level of medical devices, focusing on the development of imaging equipment, medical robots and other high-performance diagnosis and treatment equipment..." 2) "14th Five-Year" robot industry development plan proposed: "By 2025, the mainland will become a global robot technology innovation source, high-end manufacturing agglomeration and a new highland for integrated applications." "3) The Opinions of the General Office of the State Council on Promoting the High-quality Development of Public Hospitals proposes: "Vigorously develop telemedicine and Internet diagnosis and treatment." Promote the research and development and application of intelligent medical devices and intelligent auxiliary diagnosis and treatment systems such as surgical robots. "4) In the "14th Five-Year Plan" Medical Equipment Industry Development Plan, it is proposed: "Encourage qualified areas to carry out the construction of medical equipment application and promotion centers, and actively explore models such as 'purchasing technical services'." ”
Q: How is the company's products going to sea-related certification work?
A: The company has passed CSA certification and obtained the certification certificate, which has laid a solid foundation for the commercial expansion of the company's products in the international market. The company is the first surgical robot company in China to obtain CSA certification, and CE certification work is being promoted.
Q: Total surgical volume? How much surgery in 2021?
A: By the end of 2021, more than 20,000 surgeries have been completed, and the total number of surgeries in 2021 has exceeded 10,000.
Q: What are the current technological breakthroughs?
A: 1) Surgical robot fusion ultrasonic bone knife system. In September 2021, with the assistance of the surgical robot fusion ultrasonic bone knife system, the chief physician team of Yuan Qiang of the spine surgery team of Academician Tian Wei of Beijing Jishuitan Hospital successfully carried out three cases of ossification of the thoracic ligament flavonum. The robot fusion ultrasonic bone knife system used for surgery realizes the three-dimensional image planning, and the robot controls the ultrasonic bone knife to achieve accurate active osteotomy of complex shapes. The combination of the high precision of the robot and the advantages of the ultrasonic bone knife "eating soft, not eating hard" makes precise and safe cutting possible.
2) Surgical robot integrated high-speed grinding drilling system. In December 2021, the team of Professor Zhu Yue, Vice President of the First Affiliated Hospital of China Medical University and Director of the Department of Orthopedics, successfully completed two consecutive cases of lumbar lamina decompression and pedicle screw insertion assisted by orthopedic surgical robots. The robot integrates a high-speed grinding drilling system to apply robot technology to the lumbar laminal plate grinding to reduce pressure, expanding the functions of the spinal surgery robot.
At present, the successful implementation of the above surgery has broken through the limitations of the original navigation and positioning function of the orthopedic surgical robot. The above-mentioned surgical robot fusion ultrasonic bone knife system and surgical robot fusion high-speed grinding system are still in the pre-research stage, and it will take time to commercialize and commercialize.
Q: How did sales realize last year?
A: The company disclosed the 2021 annual performance express report on February 26, 2022, and after preliminary accounting, the company achieved sales revenue of about 160 million yuan in 2021, an increase of 17.50% over 2020. In fiscal 2021, the company's sales and sales of orthopedic surgical robots increased. According to the preliminary statistics made by the company based on public bidding information, the company's market share has been further improved in 2021.
Q: How is Medicare advancing?
A: Being able to charge is the premise of inclusion in medical insurance, and it can be evaluated in medical insurance after a certain period of charging. By the end of last year, the company's orthopedic surgical robot products have entered the charging directory of 20 provinces/cities. "Robot-assisted orthopedic surgery" and "disposable robot-specific instruments" have been included in the Beijing Medical Insurance Payment Catalogue and officially implemented on October 23, 2021. The cost of "robot-assisted orthopedic surgery" is fully reimbursed by Medical Insurance, and the cost of "disposable robot-specific instruments" is 70% reimbursed by Medical Insurance. The specific results of other provinces and cities entering medical insurance ultimately need to be subject to the approval of local governments.
Q: At the end of last year, the national 14th Five-Year Plan for Medical Equipment Development was released, allowing the exploration of the "purchase service model", did the company carry out the "purchase service model"? How to calculate the price of consumables in this mode?
A: The company has hospitals that carry out the "purchase service model", such as Haidian Hospital. Haidian Hospital pays the company according to the amount of surgery, and under this model, the threshold for robots to enter the hospital is greatly reduced, which can make our equipment quickly layout and also help to increase the amount of surgery. This model is still being explored by our company, and cooperation with different hospitals has not yet formed a unified and standardized model. Standardizing the model in the future is the direction of our efforts.
The "14th Five-Year Plan for the Development of the Medical Equipment Industry" released on December 28, 2021 proposes: "Encourage qualified areas to carry out the construction of medical equipment application and promotion centers, and actively explore models such as "purchasing technical services". "The release of the planning document will be conducive to the application and promotion of the company's products."
Q: How does the "Guidelines on Improving the Price of Auxiliary Operations such as "Surgical Robots" and "3D Printing" and Related Policies in Orthopedics (Draft for Comments) have an impact on the company?
A: This is an internal document of the National Medical Insurance Bureau soliciting opinions from local medical insurance bureaus, which has not yet been officially implemented and implemented, and we cannot predict it at this stage. But there has been no change in the state's strategy to encourage the development of innovative medical (002173) equipment.
Q: Will orthopedic surgical robots be included in the DRG charging program?
A: It is uncertain whether orthopedic surgical robots will be included in the DRG fee program.
Q: In terms of sales, the company's overall strategic policy?
A: With the strengthening of clinical support services as the starting point, the sense of acquisition of doctors in clinical surgery and the benefits of patients are enhanced, so as to drive the increase in the volume of surgery, and then the increase in the number of operations to drive the expected improvement of commercial prospects, thereby driving the increase in equipment sales. Through the increase in equipment ownership, the increase in the number of surgeries is further promoted, which leads to the increase in consumables revenue and service revenue.
Q: What is the progress of the fixed increase?
A: The company's application to issue A-share shares to specific targets is in the review stage of the CSRC, and we will disclose new developments in a timely manner.
Q: Equity Incentive Plan?
A: The company does not rule out the possibility of implementing the equity incentive plan in the future, if there are relevant arrangements, we will review and fulfill the information disclosure obligations in accordance with the requirements of relevant laws and regulations and regulations, please refer to the company's announcement.
Q: The progress of joint robot research and development?
A: The company's joint robot products currently under research include TKA (Total Knee Replacement Robot, TiRobot Recon) and THA (Total Hip Replacement Robot). The product under development, TKA (Total Knee Replacement Robot, TiRobot Recon), has passed the special review procedure for innovative medical devices and entered the clinical verification stage, and the clinical verification work is nearing completion; the THA (Total Hip Replacement Robot) under development is in the research and development stage.
Beijing Tianzhihang Medical Technology Co., Ltd. is a leading enterprise in the domestic orthopedic surgical robot industry, and has always focused on the research and development, production, sales and service of orthopedic surgical navigation and positioning robots. The main products are orthopedic surgical navigation and positioning robots, supporting equipment and consumables, technical services, and professional engineering of surgical centers. The company is a leading enterprise in China's orthopedic surgical robot industry, a top 10 member enterprise of Chinese robots, and a supporting unit of national and local joint engineering research centers for medical robots.
Invest in the industry leader and hidden champion in hard technology enterprises, attach importance to post-investment empowerment, and accompany the growth of enterprises... It is what Jiuzhao Investment has been insisting on, and we look forward to establishing contacts with like-minded partners and moving forward hand in hand.
—END—
Source: Flush Finance
Jiuzhao Investment is committed to creating a wealth management ecosystem for high-net-worth investors and powerful institutional investors, integrating industrial and financial resources with value investment concepts and new investment banking thinking, empowering outstanding enterprises and entrepreneurs, and maximizing the interests and social benefits of invested enterprises. Jiuzhao Investment focuses on the investment and mergers and acquisitions of high-growth emerging industries such as high-end intelligent manufacturing, artificial intelligence big data, new generation information technology, new energy and new materials, biomedical health, etc., and the core advantage is "professional depth + value investment + comprehensive empowerment".
Nine Trillion Investments
Jingjiu Zhizhao invests for you